T-CELL RESPONSE OF ADVANCED AIDS PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

被引:1
作者
Ai-xia Wang*
机构
关键词
acquired immune deficiency syndrome; highly active antiretroviral therapy; immune reconstitution;
D O I
暂无
中图分类号
R512.91 [获得性免疫缺陷综合征(AIDS艾滋病)];
学科分类号
100401 ;
摘要
Objective To investigate the response on late stage Chinese AIDS patients after highly active antiretroviral therapy (HAART). Methods From October 2002 to March 2004, 20 cases of late stage Chinese AIDS patients were selected to particip-ate in this opened and randomised study, we purposely chose those with CD4+ T cell counts < 100/mm3. All of them had one or two opportunistic infections and none had been treated with anti-HIV drugs. All patients were tested with CD4+ (naive CD4+ T cell defined by CD45RA+ and CD62L+, memory CD4+ T cell defined by CD45RA-), CD8+ T cell, plasma HIV viral load, and clinical manifestations on before, during, and after HAART (5 different regimes) on 1, 3, 6, 9, and 12 months. Results Before HAART mean CD4+ T cell counts were 32 ± 31(range 2-91)/mm3, and plasma HIV viral load were 5.07 ± 0.85(range 2.04-5.70) log copies/mL. In 1 month’s time patients treated with HAART had mean CD4+ and CD8+ T cell counts increasing rapidly. After 1 month the increasing speed turned to slow down, but HIV viral load decreased predominantly within the first 3 months. The major part of increasing CD4+ T cells were memory CD4+ T cells, as for naive CD4+ T cells increasing low and slow. Clinical symptoms and signs improved, and opportunistic infections reduced. The quality of life will be far much better than before. Each patient was followed for 12 months, and had finished 12 months’ HAART. Conclusion This is the first report in China that late stage Chinese AIDS patients after HAART could have their immune reconstitution. The regular pattern is similar to what had been reported in Western countries and also in China. So it is worth to treat late stage Chinese AIDS patients with HAART.
引用
收藏
页码:223 / 225
页数:3
相关论文
共 50 条
  • [41] Presence of HIV-specific CD4+ T-cell responses in HIV-infected subjects with sustained virologic control after highly active antiretroviral therapy
    Lacabaratz-Porret, C
    Viard, JP
    Goujard, C
    Lévy, Y
    Rodallec, A
    Deveau, C
    Venet, A
    Sinet, M
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) : 594 - 599
  • [42] Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
    Corona, Alberto
    Raimondi, Ferdinando
    CURRENT HIV RESEARCH, 2009, 7 (06) : 569 - 579
  • [43] Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia
    Anteneh Amsalu
    Kindie Desta
    Demiss Nigussie
    Demoze Delelegne
    International Journal of Ophthalmology, 2017, (05) : 776 - 781
  • [44] Antibody reactivity to HIV-1 Vpu in HIV-1/AIDS patients on highly active antiretroviral therapy
    Chen, YMA
    Rey, WY
    Can, YC
    Lai, SF
    Huang, YC
    Wu, SI
    Liu, TT
    Hsiao, KJ
    JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (02) : 266 - 275
  • [45] Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma
    Bundow, D
    Aboulafia, DM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 81 - 84
  • [46] Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic
    Olisah, V. O.
    Baiyewu, O.
    Sheikh, T. L.
    AFRICAN JOURNAL OF PSYCHIATRY, 2010, 13 (04) : 275 - 279
  • [47] Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia
    Amsalu, Anteneh
    Desta, Kindie
    Nigussie, Demiss
    Delelegne, Demoze
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (05) : 776 - 781
  • [48] Ocular Complications in Patients on Highly Active Antiretroviral Therapy: A Case Report
    Dash, Shovna
    Mohanty, Soumya Kanta
    Mohanty, Gayatree
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [49] Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions
    Husstedt, I. W.
    Reichelt, D.
    Neuen-Jakob, E.
    Hahn, K.
    Kaestner, F.
    von Einsiedel, R.
    Vielhaber, B.
    Arendt, G.
    Evers, S.
    NERVENARZT, 2009, 80 (10): : 1133 - +
  • [50] Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival
    Hendrickson, Sher L.
    Jacobson, Lisa P.
    Nelson, George W.
    Phair, John P.
    Lautenberger, James
    Johnson, Randall C.
    Kingsley, Lawrence
    Margolick, Joseph B.
    Detels, Roger
    Goedert, James J.
    O'Brien, Stephen J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (03) : 263 - 271